- Home
- BCAX vs ERII Comparison
BCAX vs ERII Comparison
Compare BCAX & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- ERII
- Stock Information
- Founded
- BCAX 2018
- ERII 1992
- Country
- BCAX United States
- ERII United States
- Employees
- BCAX N/A
- ERII N/A
- Industry
- BCAX
- ERII Industrial Machinery/Components
- Sector
- BCAX
- ERII Technology
- Exchange
- BCAX NYSE
- ERII Nasdaq
- Market Cap
- BCAX 670.9M
- ERII 675.8M
- IPO Year
- BCAX 2024
- ERII 2008
- Fundamental
- Price
- BCAX $9.32
- ERII $12.00
- Analyst Decision
- BCAX Strong Buy
- ERII Strong Buy
- Analyst Count
- BCAX 7
- ERII 4
- Target Price
- BCAX $29.17
- ERII $18.88
- AVG Volume (30 Days)
- BCAX 1.4M
- ERII 424.6K
- Earning Date
- BCAX 08-16-2025
- ERII 07-30-2025
- Dividend Yield
- BCAX N/A
- ERII N/A
- EPS Growth
- BCAX N/A
- ERII 9.93
- EPS
- BCAX N/A
- ERII 0.37
- Revenue
- BCAX N/A
- ERII $140,923,000.00
- Revenue This Year
- BCAX N/A
- ERII $4.82
- Revenue Next Year
- BCAX N/A
- ERII $12.97
- P/E Ratio
- BCAX N/A
- ERII $32.41
- Revenue Growth
- BCAX N/A
- ERII 10.93
- 52 Week Low
- BCAX $7.80
- ERII $10.86
- 52 Week High
- BCAX $28.09
- ERII $20.27
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- ERII 39.24
- Support Level
- BCAX N/A
- ERII $12.10
- Resistance Level
- BCAX N/A
- ERII $12.65
- Average True Range (ATR)
- BCAX 0.00
- ERII 0.29
- MACD
- BCAX 0.00
- ERII 0.04
- Stochastic Oscillator
- BCAX 0.00
- ERII 17.39
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the global reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.